9.56 (-%)
As of Nov 11, 2024
Source:
Corvus Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. Our strategy is to focus our efforts on the development of immune modulator product candidates with the potential to treat solid cancers, T cell lymphomas, autoimmune, allergic and infectious diseases.
| Country | United States |
| Headquarters | burlingame , california |
| Phone Number | ( 650 ) 900-4520 |
| Industry | manufacturing |
| CEO | Richard A. Miller |
| Website | www.corvuspharma.com |